Whole-genome sequencing for the diagnosis of drug-resistant tuberculosis

The Lancet Infectious Diseases

Volumn 16, Issue 1, 2016, Pages 17-

  Javid, Babak ^a,b   Török, M Estée ^b,c,d  

^a Tsinghua University   (China)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; OFLOXACIN; PYRAZINAMIDE; PYRAZINOIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

DRUG RESISTANT TUBERCULOSIS; HUMAN; LETTER; MUTATION; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; WHOLE GENOME SEQUENCING; ANTIBIOTIC RESISTANCE; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GENOTYPING TECHNIQUE; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; GENOTYPING TECHNIQUES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84974806020     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00474-0     Document Type: Letter

References (4)

1. Walker, TM, Kohl, TA, Omar, SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15 (2015), 1193–1202.
2. Feuerriegel, S, Koser, CU, Richter, E, Niemann, S, Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid. J Antimicrob Chemother 68 (2013), 1439–1440.
3. Li, H, Kayani, MU, Gu, Y, et al. Transmitted extended-spectrum extensively drug-resistant tuberculosis in Beijing, China, with discordant whole-genome sequencing analysis results. J Clin Microbiol 53 (2015), 2781–2784.
4. Koser, CU, Javid, B, Liddell, K, et al. Drug-resistance mechanisms and tuberculosis drugs. Lancet 385 (2015), 305–307.